Skip to main content

Advertisement

SpringerLink
Log in

Overexpression of ST7-AS1 Enhances Apoptosis and Inhibits Proliferation of Papillary Thyroid Carcinoma Cells Via microRNA-181b-5p-Dependent Inhibition Tripartite Motif Containing 3

  • Original Paper
  • Published:
Molecular Biotechnology Aims and scope Submit manuscript

A Correction to this article was published on 22 September 2022

This article has been updated

Abstract

Long non-coding RNAs (lncRNAs) are of great significance in the pathogenesis and progression of papillary thyroid carcinoma (PTC). LncRNA tumorigenicity 7 antisense RNA 1 (ST7-AS1) is a newly identified lncRNA serving as an oncogene or tumor suppressor in different tumors; however, the role of ST7-AS1 in PTC remains completely unknown. In this study, ST7-AS1 was mainly distributed in the cytoplasm of PTC cells and presented reduced expression in THCA tumors and PTC cell lines. Functional experiments revealed that overexpressed ST7-AS1 inhibited the viability and proliferation of PTC cells, whereas accelerated the apoptosis of PTC cells. The expression of miR-181b-5p was upregulated and it bound with ST7-AS1 in PTC cells. Moreover, TRIM3 exhibited downregulated expression level in PTC cells and ST7-AS1 elevated TRIM3 expression via harboring miR-181b-5p. Rescue experiments illuminated that knockdown of TRIM3 reversed ST7-AS1 overexpression-induced promotion on PTC cell proliferation and suppression on PTC cell apoptosis. Overall, overexpression of ST7-AS1 enhances apoptosis and represses proliferation of PTC cells via targeting the miR-181b-5p/TRIM3 axis, which may help broaden the horizon and establish the foundation to develop therapeutic strategies for PTC in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Change history

References

  1. Ramírez-Moya, J., Wert-Lamas, .L, Acuña-Ruíz, A., Fletcher, A., Wert-Carvajal, C., McCabe, C. J., Santisteban, P. & Riesco-Eizaguirre, G. (2022). Identification of an interactome network between lncRNAs and miRNAs in thyroid cancer reveals SPTY2D1-AS1 as a new tumor suppressor. Scientific Reports 12(1), 7706.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2022). Cancer statistics, 2022. CA: A Cancer Journal for Clinicians, 72(1), 7–33.

    PubMed  Google Scholar 

  3. Tian, J., & Luo, B. (2022). Identification of three prognosis-related differentially expressed lncRNAs driven by copy number variation in thyroid cancer. Journal of Immunology Research, 2022, 9203796.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Zeng, Z., Teng, Q., & Xiao, J. (2021). Long noncoding RNA ILF3-AS1 aggravates papillary thyroid carcinoma progression via regulating the miR-4306/PLAGL2 axis. Cancer Cell International, 21(1), 322.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Davies, L., & Welch, H. G. (2014). Current thyroid cancer trends in the United States. JAMA Otolaryngology. Head & Neck Surgery, 140(4), 317–322.

    Article  Google Scholar 

  6. Zheng, H., Wang, M., Jiang, L., Chu, H., Hu, J., Ning, J., Li, B., Wang, D., & Xu, J. (2016). BRAF-activated long noncoding RNA modulates papillary thyroid carcinoma cell proliferation through regulating thyroid stimulating hormone receptor. Cancer Research and Treatment, 48(2), 698–707.

    Article  CAS  PubMed  Google Scholar 

  7. Xing, M. (2013). Molecular pathogenesis and mechanisms of thyroid cancer. Nature Reviews Cancer, 13(3), 184–199.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Hundahl, S. A., Fleming, I. D., Fremgen, A. M., & Menck, H. R. (1998). A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer: Interdisciplinary International Journal of the American Cancer Society, 83(12), 2638–2648.

    Article  CAS  Google Scholar 

  9. Shoup, M., Stojadinovic, A., Nissan, A., Ghossein, R. A., Freedman, S., Brennan, M. F., Shah, J. P., & Shaha, A. R. (2003). Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma. Journal of the American College of Surgeons, 197(2), 191–197.

    Article  PubMed  Google Scholar 

  10. Huang, C., Su, X., Zhou, D. L., Xu, B. H., Liu, Q., Zhang, X., Tang, T., Yang, X. H., Ye, Z. L., & He, C. Y. (2022). A diagnostic and predictive lncRNA lnc-MPEG1-1 promotes the proliferation and metastasis of papillary thyroid cancer cells by occupying miR-766-5p. Molecular Therapy Nucleic Acids, 28, 408–422.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Shen, Y., Liu, S., Fan, J., Jin, Y., Tian, B., Zheng, X., & Fu, H. (2017). Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions. EMBO Reports, 18(4), 536–548.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Qi, X., Zhang, D. H., Wu, N., Xiao, J. H., Wang, X., & Ma, W. (2015). ceRNA in cancer: possible functions and clinical implications. Journal of Medical Genetics, 52(10), 710–718.

    Article  PubMed  Google Scholar 

  13. Bhan, A., Soleimani, M., & Mandal, S. S. (2017). Long noncoding RNA and cancer: A new paradigm. Cancer Research, 77(15), 3965–3981.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Cao, J., Zhang, M., Zhang, L., Lou, J., Zhou, F., & Fang, M. (2021). Non-coding RNA in thyroid cancer - Functions and mechanisms. Cancer Letters, 496, 117–126.

    Article  CAS  PubMed  Google Scholar 

  15. Wen, Q., Zhao, L., Wang, T., Lv, N., Cheng, X., Zhang, G., & Bai, L. (2021). LncRNA SNHG16 drives proliferation and invasion of papillary thyroid cancer through modulation of miR-497 [Retraction]. OncoTargets and Therapy, 14, 4747–4748.

    Article  Google Scholar 

  16. Wu, L., Ding, Y., Tong, H., Zhuang, X., Cai, J., Si, Y., Zhang, H., Wang, X., & Shen, M. (2021). Long noncoding RNA FER1L4 promotes the malignant processes of papillary thyroid cancer by targeting the miR-612/ Cadherin 4 axis. Cancer Cell International, 21(1), 392.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zhou, B., Ge, Y., Shao, Q., Yang, L., Chen, X., & Jiang, G. (2021). Long noncoding RNA LINC00284 facilitates cell proliferation in papillary thyroid cancer via impairing miR-3127-5p targeted E2F7 suppression. Cell Death Discovery, 7(1), 156.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Guan, Y., Li, Y., Yang, Q. B., Yu, J., & Qiao, H. (2021). LncRNA ABCC6P1 promotes proliferation and migration of papillary thyroid cancer cells via Wnt/β-catenin signaling pathway. Annals of Translational Medicine, 9(8), 664.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Murugan, A. K., Munirajan, A. K., & Alzahrani, A. S. (2018). Long noncoding RNAs: Emerging players in thyroid cancer pathogenesis. Endocrine-Related Cancer, 25(2), R59–R82.

    Article  CAS  PubMed  Google Scholar 

  20. Qi, H., Lu, L., & Wang, L. (2020). Long noncoding RNA ST7-AS1 upregulates TRPM7 expression by sponging microRNA-543 to promote cervical cancer progression. OncoTargets and Therapy, 13, 7257–7269.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Hu, R. H., Zhang, Z. T., Wei, H. X., Ning, L., Ai, J. S., Li, W. H., Zhang, H., & Wang, S. Q. (2020). LncRNA ST7-AS1, by regulating miR-181b-5p/KPNA4 axis, promotes the malignancy of lung adenocarcinoma. Cancer Cell International, 20(1), 568.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Qin, H., Xu, J., Gong, L., Jiang, B., & Zhao, W. (2019). The long noncoding RNA ST7-AS1 promotes laryngeal squamous cell carcinoma by stabilizing CARM1. Biochemical and Biophysical Research Communications, 512(1), 34–40.

    Article  CAS  PubMed  Google Scholar 

  23. Sheng, J., He, X., Yu, W., Chen, Y., Long, Y., Wang, K., Zhu, S., & Liu, Q. (2021). p53-targeted lncRNA ST7-AS1 acts as a tumour suppressor by interacting with PTBP1 to suppress the Wnt/β-catenin signalling pathway in glioma. Cancer Letters, 503, 54–68.

    Article  CAS  PubMed  Google Scholar 

  24. Yang, F., Zhang, J., Li, B., Zhao, Z., Liu, Y., Zhao, Z., Jing, S., & Wang, G. (2021). Identification of Potential lncRNAs and miRNAs as Diagnostic Biomarkers for Papillary Thyroid Carcinoma Based on Machine Learning. International Journal of Endocrinology, 2021, 3984463.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Skjefstad, K., Johannessen, C., Grindstad, T., Kilvaer, T., Paulsen, E. E., Pedersen, M., Donnem, T., Andersen, S., Bremnes, R., Richardsen, E., Al-Saad, S., & Busund, L. T. (2018). A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer. Scientific Reports, 8(1), 8549.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Yue, J., Lv, D., Wang, C., Li, L., Zhao, Q., Chen, H., & Xu, L. (2018). Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3. Oncogene, 37(31), 4300–4312.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Yan, X., Yang, P., Liu, H., Zhao, Y., Wu, Z., & Zhang, B. (2022). miR-4461 inhibits the progression of gallbladder carcinoma via regulating EGFR/AKT signaling. Cell Cycle (Georgetown, Tex). https://doi.org/10.1080/15384101.2022.2042775

    Article  PubMed  PubMed Central  Google Scholar 

  28. Jin, X., Qiu, X., Huang, Y., Zhang, H., & Chen, K. (2022). miR-223-3p carried by cancer-associated fibroblast microvesicles targets SORBS1 to modulate the progression of gastric cancer. Cancer Cell International, 22(1), 96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Li, X., Zhu, M., Zhao, G., Zhou, A., Min, L., Liu, S., Zhang, N., Zhu, S., Guo, Q., Zhang, S., & Li, P. (2022). MiR-1298-5p level downregulation induced by Helicobacter pylori infection inhibits autophagy and promotes gastric cancer development by targeting MAP2K6. Cellular Signalling, 93, 110286.

    Article  CAS  PubMed  Google Scholar 

  30. Qin, Y., Zheng, Y., Huang, C., Li, Y., Gu, M., & Wu, Q. (2021). Downregulation of miR-181b-5p inhibits the viability, migration, and glycolysis of gallbladder cancer by upregulating PDHX under hypoxia. Frontiers in Oncology, 11, 683725.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Koi, M., Johnson, L. A., Kalikin, L. M., Little, P. F., Nakamura, Y., & Feinberg, A. P. (1993). Tumor cell growth arrest caused by subchromosomal transferable DNA fragments from chromosome 11. Science (New York, NY), 260(5106), 361–364.

    Article  CAS  Google Scholar 

  32. El-Husseini, A. E., Fretier, P., & Vincent, S. R. (2001). Cloning and characterization of a gene (RNF22) encoding a novel brain expressed ring finger protein (BERP) that maps to human chromosome 11p15.5. Genomics, 71(3), 363–367.

    Article  CAS  PubMed  Google Scholar 

  33. Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017). GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Research, 45(W1), W98–W102.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Li, J. H., Liu, S., Zhou, H., Qu, L. H., & Yang, J. H. (2014). starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Research, 42(Database issue), D92–D97. https://doi.org/10.1093/nar/gkt1248

    Article  CAS  PubMed  Google Scholar 

  35. Liu, H., Deng, H., Zhao, Y., Li, C., & Liang, Y. (2018). LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling. Journal of Experimental & Clinical Cancer Research : CR, 37(1), 279.

    Article  CAS  PubMed Central  Google Scholar 

  36. Liu, X., Li, L., Bai, J., Li, L., Fan, J., Fu, Z., & Liu, J. (2022). Long noncoding RNA plasmacytoma variant translocation 1 promotes progression of colorectal cancer by sponging microRNA-152-3p and regulating E2F3/MAPK8 signaling. Cancer Science, 113(1), 109–119.

    Article  CAS  PubMed  Google Scholar 

  37. Zhen, Q., Gao, L. N., Wang, R. F., Chu, W. W., Zhang, Y. X., Zhao, X. J., Lv, B. L., & Liu, J. B. (2018). LncRNA DANCR promotes lung cancer by sequestering miR-216a. Cancer Control : Journal of the Moffitt Cancer Center, 25(1), 1073274818769849.

    Article  PubMed  Google Scholar 

  38. Shi, Q., Li, Y., Li, S., Jin, L., Lai, H., Wu, Y., Cai, Z., Zhu, M., Li, Q., Li, Y., Wang, J., Liu, Y., Wu, Z., Song, E., & Liu, Q. (2020). LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer. Nature Communications, 11(1), 5513.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Ning, M., Qin, S., Tian, J., Wang, Y., & Liu, Q. (2021). LncRNA AFAP-AS1 promotes anaplastic thyroid cancer progression by sponging miR-155-5p through ETS1/ERK pathway. Bioengineered, 12(1), 1543–1554.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Jiang, L., Wu, Z., Meng, X., Chu, X., Huang, H., & Xu, C. (2019). LncRNA HOXA-AS2 Facilitates Tumorigenesis and Progression of Papillary Thyroid Cancer by Modulating the miR-15a-5p/HOXA3 Axis. Human Gene Therapy, 30(5), 618–631.

    Article  CAS  PubMed  Google Scholar 

  41. Lamartina, L., Grani, G., Arvat, E., Nervo, A., Zatelli, M. C., Rossi, R., Puxeddu, E., Morelli, S., Torlontano, M., Massa, M., Bellantone, R., Pontecorvi, A., Montesano, T., Pagano, L., Daniele, L., Fugazzola, L., Ceresini, G., Bruno, R., Rossetto, R., … Durante, C. (2018). 8th edition of the AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2). Endocrine-Related Cancer, 25(3), L7–L11.

    Article  PubMed  Google Scholar 

  42. Sui, F., Ji, M., & Hou, P. (2018). Long non-coding RNAs in thyroid cancer: Biological functions and clinical significance. Molecular and Cellular Endocrinology, 469, 11–22.

    Article  CAS  PubMed  Google Scholar 

  43. Naoum, G. E., Morkos, M., Kim, B., & Arafat, W. (2018). Novel targeted therapies and immunotherapy for advanced thyroid cancers. Molecular Cancer, 17(1), 51.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Hu, Y., Tang, J., Xu, F., Chen, J., Zeng, Z., Han, S., Wang, F., Wang, D., Huang, M., Zhao, Y., Huang, Y., Zhuo, W., & Zhao, G. (2022). A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p. Journal of Experimental & Clinical Cancer Research : CR, 41(1), 69.

    Article  CAS  PubMed Central  Google Scholar 

  45. Li, D., Xu, M., Wang, Z., Huang, P., Huang, C., Chen, Z., Tang, G., Zhu, X., Cai, M., & Qin, S. (2022). The EMT-induced lncRNA NR2F1-AS1 positively modulates NR2F1 expression and drives gastric cancer via miR-29a-3p/VAMP7 axis. Cell Death & Disease, 13(1), 84.

    Article  CAS  Google Scholar 

  46. Mei, J., Lin, W., Li, S., Tang, Y., Ye, Z., Lu, L., Wen, Y., Kan, A., Zou, J., Yu, C., Wei, W., & Guo, R. (2022). Long noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p/ST6GAL1/NF-κB pathway. Journal of Experimental & Clinical Cancer Research : CR, 41(1), 5.

    Article  CAS  PubMed Central  Google Scholar 

  47. Fan, Y., Fan, X., Yan, H., Liu, Z., Wang, X., Yuan, Q., Xie, J., Lu, X., & Yang, Y. (2022). Long non-coding ROR promotes the progression of papillary thyroid carcinoma through regulation of the TESC/ALDH1A1/TUBB3/PTEN axis. Cell Death & Disease, 13(2), 157.

    Article  CAS  Google Scholar 

  48. Zhou, P., Xu, T., Hu, H., & Hua, F. (2021). Overexpression of PAX8-AS1 inhibits malignant phenotypes of papillary thyroid carcinoma cells via miR-96-5p/PKN2 axis. International Journal of Endocrinology, 2021, 5499963.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Zhang, Z., Zhang, H., Li, D., Zhou, X., Wang, J., & Zhang, Q. (2021). LncRNA ST7-AS1 is a potential novel biomarker and correlated with immune infiltrates for breast cancer. Frontiers in Molecular Biosciences, 8, 604261.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Cai, S., Weng, Y., Liu, P., & Miao, F. (2020). Knockdown of ST7-AS1 inhibits migration, invasion, cell cycle progression and induces apoptosis of gastric cancer. Oncology Letters, 19(1), 777–782.

    CAS  PubMed  Google Scholar 

  51. Chen, G., Peng, L., Zhu, Z., Du, C., Shen, Z., Zang, R., Su, Y., Xia, Y., & Tang, W. (2017). LncRNA AFAP1-AS functions as a competing endogenous RNA to regulate RAP1B expression by sponging miR-181a in the HSCR. International Journal of Medical Sciences, 14(10), 1022–1030.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Wu, K., Huang, J., Xu, T., Ye, Z., Jin, F., Li, N., & Lv, B. (2019). MicroRNA-181b blocks gensenoside Rg3-mediated tumor suppression of gallbladder carcinoma by promoting autophagy flux via CREBRF/CREB3 pathway. American Journal of Translational Research, 11(9), 5776–5787.

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Jiang, Z. L., Zhang, F. X., Zhan, H. L., Yang, H. J., Zhang, S. Y., Liu, Z. H., Jiang, Y., Lv, L. Z., & Ke, R. S. (2022). miR-181b-5p promotes the progression of cholangiocarcinoma by targeting PARK2 via PTEN/PI3K/AKT signaling pathway. Biochemical Genetics, 60(1), 223–240.

    Article  CAS  PubMed  Google Scholar 

  54. Wang, Y., Lu, J., Chen, L., Bian, H., Hu, J., Li, D., Xia, C., & Xu, H. (2020). Tumor-derived EV-encapsulated miR-181b-5p induces angiogenesis to foster tumorigenesis and metastasis of ESCC. Molecular Therapy-Nucleic Acids, 20, 421–437.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Hu, C. E., & Gan, J. (2017). TRIM37 promotes epithelial-mesenchymal transition in colorectal cancer. Molecular Medicine Reports, 15(3), 1057–1062.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Ye, R., AiErken, N., Kuang, X., Zeng, H., Shao, N., Lin, Y., Liu, P., & Wang, S. (2021). Tripartite motif-containing 3 (TRIM3) enhances ER signaling and confers tamoxifen resistance in breast cancer. Oncogenesis, 10(9), 60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Huang, X. Q., Zhang, X. F., Xia, J. H., Chao, J., Pan, Q. Z., Zhao, J. J., Zhou, Z. Q., Chen, C. L., Tang, Y., Weng, D. S., & Zhang, J. H. (2017). Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer. Chinese Journal of Cancer, 36(1), 77.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Piao, M. Y., Cao, H. L., He, N. N., Xu, M. Q., Dong, W. X., Wang, W. Q., Wang, B. M., & Zhou, B. (2016). Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development. Scandinavian Journal of Gastroenterology, 51(5), 572–582.

    Article  CAS  PubMed  Google Scholar 

  59. Chen, G., Kong, J., Tucker-Burden, C., Anand, M., Rong, Y., Rahman, F., Moreno, C. S., Van Meir, E. G., Hadjipanayis, C. G., & Brat, D. J. (2014). Human brat ortholog TRIM3 is a tumor suppressor that regulates asymmetric cell division in glioblastoma. Cancer Research, 74(16), 4536–4548.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. Yuan Zhao and Xiaoyun Feng have contributed equally to the work.

Authors and Affiliations

  1. Department of Pathology, The First People’s Hospital of Lianyungang, Lianyungang, 222000, Jiangsu, China

    Yuan Zhao & Yonggang Zhao

  2. Department of Pathology, ZhongShan-XuHui Hospital, FuDan University, Shanghai, 200031, China

    Xiaoyun Feng

  3. Department of Pathology, The Second People’s Hospital of Lianyungang, 41 Hailian Road, Lianyungang, 222001, Jiangsu, China

    Huijuan Yang & Chunjie Zhang

Authors
  1. Yuan Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaoyun Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yonggang Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Huijuan Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chunjie Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chunjie Zhang.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original article has been corrected to update data layout in figure 2c & 6c. Attached correct figure.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, Y., Feng, X., Zhao, Y. et al. Overexpression of ST7-AS1 Enhances Apoptosis and Inhibits Proliferation of Papillary Thyroid Carcinoma Cells Via microRNA-181b-5p-Dependent Inhibition Tripartite Motif Containing 3. Mol Biotechnol 65, 477–490 (2023). https://doi.org/10.1007/s12033-022-00536-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12033-022-00536-7

Keywords

Search

Navigation